Grandfield & Dodd’s GE HealthCare GEHC Stock Holding History

Grandfield & Dodd’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$21.9M	Sell	335,368 -1,876	-0.6%	-$127K	1.17%	31
2026 Q2	$21.6M	Buy	337,244 +220	+0.1%	+$14.5K	1.13%	28
2026 Q1	$24M	Buy	337,024 +1,616	+0.5%	+$127K	1.35%	25
2025 Q4	$27.5M	Buy	335,408 +1,117	+0.3%	+$87K	1.56%	21
2025 Q3	$25.1M	Buy	334,291 +1,816	+0.5%	+$135K	1.42%	22
2025 Q2	$24.6M	Buy	332,475 +2,827	+0.9%	+$197K	1.44%	23
2025 Q1	$26.6M	Buy	329,648 +5,581	+2%	+$480K	1.65%	21
2024 Q4	$25.3M	Buy	324,067 +1,178	+0.4%	+$100K	1.56%	25
2024 Q3	$30.3M	Buy	322,889 +2,101	+0.7%	+$176K	1.8%	21
2024 Q2	$25M	Buy	320,788 +5,103	+2%	+$416K	1.58%	22
2024 Q1	$28.7M	Buy	315,685 +16,800	+6%	+$1.4M	1.81%	21
2023 Q4	$23.1M	Buy	298,885 +76,035	+34%	+$5.32M	1.6%	24
2023 Q3	$15.2M	Buy	222,850 +98,218	+79%	+$7.15M	1.11%	39
2023 Q2	$10.1M	Buy	124,632 +42,392	+52%	+$3.38M	0.71%	51
2023 Q1	$6.75M	Buy	+82,240	New	+$5.87M	0.47%	55

Other funds holding GEHC

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Locust Wood Capital Advisers New York $4.43B AUM 19.95% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

Grandfield & Dodd's GEHC Position: Q3 2026 in Review

Grandfield & Dodd reduced its GE HealthCare (GEHC) stake by 0.56% in Q3 2026, selling an estimated $127K and leaving 335,368 shares worth $21.9M. The position accounts for 1.17% of the portfolio, ranked #31.

Grandfield & Dodd first reported a position in GEHC in Q1 2023 and has held it in 15 quarters since. The position peaked at $30.3M in Q3 2024. 657 funds tracked by Wall St. Rank hold GEHC as of Q3 2026.

Grandfield & Dodd held 335,368 shares of GE HealthCare worth $21.9M as of Q3 2026.
Grandfield & Dodd sold 1,876 GE HealthCare shares in Q3 2026, an estimated $127K.
GE HealthCare made up 1.17% of Grandfield & Dodd's portfolio in Q3 2026, its #31 holding.
Grandfield & Dodd first reported a position in GE HealthCare in Q1 2023 and has held it in 15 quarters since.
Grandfield & Dodd's GE HealthCare position peaked at $30.3M in Q3 2024.
657 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2026.

Based on Grandfield & Dodd's 13F filing for Q3 2026, filed 29 Oct 2026.